CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $711,000 | -82.8% | 27,177 | -88.6% | 0.00% | -88.9% |
| Q3 2020 | $4,144,000 | +196.4% | 237,990 | +102.3% | 0.03% | +145.5% |
| Q1 2020 | $1,398,000 | +544.2% | 117,644 | +554.3% | 0.01% | +1000.0% |
| Q4 2019 | $217,000 | -76.1% | 17,980 | -77.9% | 0.00% | -83.3% |
| Q2 2019 | $907,000 | -70.1% | 81,348 | -68.5% | 0.01% | -45.5% |
| Q1 2019 | $3,032,000 | +54.9% | 258,270 | +76.4% | 0.01% | -42.1% |
| Q4 2018 | $1,957,000 | +91.5% | 146,423 | +125.2% | 0.02% | +216.7% |
| Q2 2018 | $1,022,000 | -80.7% | 65,012 | -79.8% | 0.01% | -76.9% |
| Q1 2018 | $5,285,000 | -40.4% | 321,264 | -31.1% | 0.03% | -53.6% |
| Q3 2017 | $8,863,000 | -36.4% | 466,460 | -59.9% | 0.06% | -45.1% |
| Q2 2017 | $13,942,000 | – | 1,161,830 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |